Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the safety of a tacrolimus modified release, MR4 , based immunosuppressive regimen in stable liver transplant subjects converted on a 1:1 (mg:mg) basis from a Prograf® based immunosuppressive regimen. Non-inferiority for creatinine clearance will be assessed.
Critère d'inclusion
- Stable, adult liver transplant recipients (≥ 12 months post transplant) who are currently treated with Prograf